M. Hamidah, A. Widyawaruyanti, W. Widjiati, and B. Prasetyo, “Sambiloto (AS201-01) is better than standard antimalarial drug (DHP) in reducing Toll-Like Receptor 2 (TLR2) on placenta malaria model”, MOG, vol. 26, no. 2, pp. 74–82, Aug. 2018.